Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 74, Issue 2, 2014, Pages 81-88

  Liebetrau, Christoph ^a   Gaede, Luise ^a   Doerr, Oliver ^b   Blumenstein, Johannes ^a   Rixe, Johannes ^b   Teichert, Olaf ^a   Willmer, Matthias ^a   Weber, Michael ^a   Rolf, Andreas ^a,b   Möllmann, Helge ^a,b   Hamm, Christian ^a,b   Nef, Holger ^a,b  

^a Kerckhoff Heart and Thorax Center   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Contrast induced acute kidney injury; Contrast induced nephropathy; LCN2; Neutrophil gelatinase associated lipocalin; Percutaneous coronary intervention

Indexed keywords

BIOLOGICAL MARKER; CONTRAST MEDIUM; CREATININE; CYSTATIN C; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UREA;

AGED; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; EARLY DIAGNOSIS; FEMALE; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CONTRAST MEDIA; CORONARY DISEASE; CREATININE; CYSTATIN C; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LIPOCALINS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84896380338     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2013.860615     Document Type: Article

References (35)

1. Thom T, Haases N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wassertheil-Smoller S, Wilson M, Wolf P. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: 85-151.
2. Berichtüber die Leistungszahlen der Herzkatheterlabore in der Bundesrepublik Deutschland [25th performance report of the German cardiac catheter laboratories]. F. van Buuren, Kardiologie 2010; 4; 502-8.
3. Nash K, Hafeez A, Hou S. Hospital-acquired renal insuffi-ciency. Am J Kidney Dis 2002; 39: 930-6.
4. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393-9. (Pubitemid 39303939)
5. Rihal CS, TextorSC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garrat KN, Holmes DR. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-64. (Pubitemid 34535335)
6. Sidhu RB, Brown JR, Robb JF, Jayne JE, Friedman BJ, Hettleman BD, Kaplan A V, Niles NW, Thompson CA. Interaction of gender and age on post cardiac catheterization contrast-induced acute kidney injury. Am J Cardiol 2008; 102: 1482-6.
7. Morabito S, Pistolesi V, Benedetti G, Di Roma A, Colantonia R, Mancone M, Sardella G, Cibelli L, Ambrosino M, Polistena F, Pierucci A. Incidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiography. J Nephrol 2012; 25: 1098-107.
8. Le Feuvre C, Dambrin G, Helft G, Tabet S, Beygui F, Legendre C, Péraldi MN, Vacheron A, Metzger JP. Comparison of clinical outcome following coronary stenting or balloon angioplasty in dialysis versus non-dialysis patients. Am J Cardiol 2000; 85: 1365-8. (Pubitemid 30314673)
9. Wi J, Ko YG, Kim JS, Kim BK, Choi D, Ha JW, Hong MK, Jang Y. Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart 2011; 97: 1753-7.
10. Devarajan P. Update on mechanisms of ischemic acute kidney injury. Comprehensive review of the pathophysiologic mechanisms that underlie AKI. J Am Soc Nephrol 2006; 17: 1503-20.
11. Devarajan P. Emerging biomarkers of acute kidney injury. Contrib Nephrol 2007; 156: 203-12.
12. Wasen E, Isoaho R, Mattila K, Vahlberg T, Kivela SL, Irjala K. Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C. J Int Med 2004; 256: 70-8. (Pubitemid 38813622)
13. Coll E, Botey A, Alvarez L, Poch E, Quintó L, Saurina A, Vera M, Piera C, Darnell A. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000; 36: 29-34. (Pubitemid 30432560)
14. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 2001: 37: 79-83. (Pubitemid 32055022)
15. Emberson JR, Haynes R, Dasgupta T, Mafham M, Landray MJ, Baigent C, Clarke R. Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older men. J Intern Med 2010; 268: 145-54.
16. Kjeldsen L, Cowland JB, Borregaard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta 2000; 18: 272-83.
17. Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P. Differential gene expression following early renal ischemia/reperfusion. Kidney Int 2003; 63: 1714-24. (Pubitemid 36513317)
18. Lavery AP, Meinzen-Derr JK, Anderson E, Ma Q, Bennett MR, Devarajan P, Schibler KR. Urinary NGAL in premature infants. Pediatr Res 2008; 64: 423-8.
19. Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S. NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine. Adv Med Sci 2009; 54: 221-4.
20. Devarajan P. Review: neutrophil gelatinase-associated lipoc-alin: a troponin-like biomarker for human acute kidney injury. Nephrology 2010; 15: 419-28.
21. Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A, Buemi M. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis 2008; 52: 595-605.
22. Shaker O, El-Shehaby A, El-Khatib M. Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography. Angiology 2010; 61: 731-6.
23. Singer E, Elger A, Elitox S, Kettritz R, Nickolas T, Barasch J, Luft F, Schmidt-Ott K. Urinary neutrophil gelatinase-associ-ated lipocalin distinguishes pre-renal from intrensic renal failure and predicts outcome. Kidney Int 2011; 80: 405-14.
24. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 2001; 37: 79-83. (Pubitemid 32055022)
25. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int (Suppl.)2012; 2: 1-138.
26. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Poniatowski B, Pawlak I, Dobrzycki S. NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine)? Int J Cardiol 2008; 127; 290-1. (Pubitemid 351795614)
27. Hemdahl A-L, Gabrielsen A, Zhu C, Eriksson P, Hedin U, Kastrup J, Thorén P, Hansson GK. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol 2006; 26: 136-42. (Pubitemid 43732240)
28. Kümpers P, Hafer C, Lukasz A, Lichtinghagen R, Brand K, Fliser D, Faulhaber-Walter R, Kielstein JT. Serum neutro-phil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Critical Care 2010; 141: 9.
29. Dent CL, Ma Q, Dastrala S, Bennett M, Mitsnefes MM, Barasch J, Devarajan P. Plasma neutrophil gelastinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007; 11: 127.
30. Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in depth review of literature. Nephrol Dial Transpl 2013; 28: 254-73.
31. Liebetrau C, Dörr O, Baumgarten H, Gaede L, Szardien S, Blumenstein J, Rolf A, Möllmann H, Hamm CW, Walther T, Nef H, Weber M. Neutrophil gelatinse-associated lipocalin (NGAL) for the early detection of cardiac surgery associated acute kidney injury. Scan J Clin Lab Med 2013; 73: 392-9.
32. Grenier FC, Ali S, Syed H, Workman R, Martens F, Liao M, Wang Y, Wong PY. Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clin Biochem 2009; 43: 615-20.
33. Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelati-nase-associated lipocalin from humans. Genomics 1997; 45: 17-23. (Pubitemid 27449379)
34. Devarajan P. Neutrophil gelatinase-associated lipocalin: new paths for an old shuttle. Cancer Ther 2007; 5(B): 463-70.
35. Decavale AS, Dhondt L, De Buyzere ML, Delanghe JR. Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infecions and leukocyturia. Clin Chem Lab Med 2011; 49: 999-1003.